GE HealthCare (GEHC) CEO reports PSU vesting and tax-withholding share disposition

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. CEO Kevin Michael O'Neill reported equity award activity in company stock. On February 12, 2026, he acquired 6,938 shares of common stock at $0 per share through the vesting of previously granted performance stock units after performance criteria were certified.

To cover related tax withholding obligations from this vesting, 3,261 shares were disposed of at a price of $79.2 per share. Following these transactions, O'Neill directly held 26,195 shares of GE HealthCare common stock and indirectly held 59 shares through a share incentive plan trust.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider O'Neill Kevin Michael

Role CEO, PDx

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	6,938	$0.00	--
Tax Withholding	Common Stock, par value $0.01 per share	3,261	$79.20	$258K
holding	Common Stock, par value $0.01 per share	--	--	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 29,456 shares (Direct); Common Stock, par value $0.01 per share — 59 shares (Indirect, By share incentive plan trust)

Footnotes (1)

1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Kevin Michael

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, PDx

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/12/2026		A		6,938(1)	A	$0	29,456	D
Common Stock, par value $0.01 per share	02/12/2026		F		3,261(2)	D	$79.2	26,195	D
Common Stock, par value $0.01 per share								59	I	By share incentive plan trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026.

2. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did GEHC CEO Kevin Michael O'Neill report?

Kevin Michael O'Neill reported vesting of performance stock units, acquiring 6,938 GE HealthCare shares at $0 per share. Part of the vested shares was used to satisfy tax withholding obligations, with remaining shares increasing his direct ownership in the company.

How many GEHC shares did the CEO acquire through PSU vesting?

He acquired 6,938 shares of GE HealthCare common stock through the vesting of performance stock units. Each PSU converted into one share after performance criteria were met and certified by the company’s Talent, Culture, and Compensation Committee.

Why were some GEHC shares disposed of in Kevin O'Neill’s Form 4 filing?

O'Neill disposed of 3,261 shares to satisfy tax withholding obligations related to the PSU vesting. This tax-withholding disposition, coded “F,” reflects shares delivered to cover taxes rather than an open-market sale transaction.

What is Kevin O'Neill’s GEHC share ownership after the reported transactions?

After the reported transactions, O'Neill directly held 26,195 GE HealthCare common shares. He also indirectly held 59 shares through a share incentive plan trust, as disclosed in the Form 4 filing’s ownership table.

What are GEHC performance stock units (PSUs) mentioned in the Form 4?

The PSUs are awards granted on March 1, 2023, each representing the right to receive one GE HealthCare share. They vested on February 12, 2026, after the company’s committee certified that the applicable performance criteria had been satisfied.